Filing Details
NEUROONE MEDICAL TECHNOLOGIES Corp (NASDAQ:NMTC) filed a Form 8-K with the Securities and Exchange Commission on August 13, 2026, disclosing a material event.
8k filedNASDAQ:NMTC
NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) Reports Material Event to SEC
NEUROONE MEDICAL TECHNOLOGIES Corp (NASDAQ:NMTC) filed a Form 8-K with the Securities and Exchange Commission on August 13, 2026, disclosing a material event.
At publication ·
What changed
NEUROONE MEDICAL TECHNOLOGIES Corp (NASDAQ:NMTC) · 8k filed
- Form
- 8-K
At a glance
Key takeaways
- NEUROONE MEDICAL TECHNOLOGIES Corp (NASDAQ:NMTC) filed a Form 8-K with the SEC on August 13, 2026, disclosing a material event that shareholders should be aware of.
- The company's stock trades at $1.83 with a market capitalization of $29.3 million.
- The article does not specify the nature of the material event, which could involve leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance.
Market Context
NEUROONE MEDICAL TECHNOLOGIES Corp's stock currently trades at $1.83 with a market capitalization of $29.3M. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for NEUROONE MEDICAL TECHNOLOGIES Corp's stock.
All SEC filings for NEUROONE MEDICAL TECHNOLOGIES Corp are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View NMTC Stock Page
Frequently Asked Questions
Where can I read NMTC's SEC filings?
Browse all filings on our NMTC SEC filings page.
What types of SEC filings does NEUROONE MEDICAL TECHNOLOGIES Corp file?
Public companies like NEUROONE MEDICAL TECHNOLOGIES Corp file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.